Insights
Access our latest insights & resources
Advisory Committee’s Split Decision on Biogen’s Tofersen
Policy & Legal, Research
We expect the FDA to grant accelerated approval of Biogen's (BIIB) ALS treatment...
Read more
Asia Foundries: Widening the Lead Is Easier Than Catching Up
Fundamental, Research
Despite flattening demand for consumer electronics, fast and efficient chips remain sought after...
Read more
What’s Next for U.S. Banking and 2023 Outlook
Webinar
Dive into the Federal Reserve mandates and functions, highlighted recent regulatory...
Read more
ETF Inflows Signal Investors Caution as the U.S. Debt Ceiling Deadling Looms
ETF & Mutual Fund, Research
Gold ETFs have taken in $2.7 billion this year through...
Read more
U.S. Banks: All Eyes on Fed Bank Supervision
Fundamental, Research
Banks face many headwinds in the eyes of investors and policymakers...
Read more
Mitigation Expectations for Medicare Advantage Rate Notice
Policy & Legal, Research
Size of Medicare Advantage mitigation may be less than earlier expectations...
Read more
In the TikTok Kerfuffle, Politics Will Win Out over National Security
Policy & Legal, Research
Policy to win out over national security concerns in TikTok debate...
Read more
Lowry Mid-Week Commentary Week of March 15, 2023
Research, Technical
Revisitation of previous week's comments reversal and sell-off...
Read more
Big Tech Cost Cuts: META Taking a Page From the Apple Efficiency Playbook
Fundamental, Research
META to rebound from heavy job cuts in 2023...
Read more
European Pharma: Top Picks as Growth Slows; New Launches and Core Products are Key
Fundamental, Research
How European Pharma fared versus consensus estimates...
Read more